IN2015DN00130A - - Google Patents

Info

Publication number
IN2015DN00130A
IN2015DN00130A IN130DEN2015A IN2015DN00130A IN 2015DN00130 A IN2015DN00130 A IN 2015DN00130A IN 130DEN2015 A IN130DEN2015 A IN 130DEN2015A IN 2015DN00130 A IN2015DN00130 A IN 2015DN00130A
Authority
IN
India
Application number
Inventor
Alexandre Vasilievich Ivachtchenko
Original Assignee
Alla Chem Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49446598&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN00130(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alla Chem Llc filed Critical Alla Chem Llc
Publication of IN2015DN00130A publication Critical patent/IN2015DN00130A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074Filling capsules; Related operations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IN130DEN2015 2012-07-11 2015-01-06 IN2015DN00130A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012129101/15A RU2496486C1 (en) 2012-07-11 2012-07-11 Pharmaceutical composition exhibiting improved flowability, drug preparation, method for preparing and using
PCT/RU2013/000572 WO2014011083A2 (en) 2012-07-11 2013-07-05 Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same

Publications (1)

Publication Number Publication Date
IN2015DN00130A true IN2015DN00130A (en) 2015-05-29

Family

ID=49446598

Family Applications (1)

Application Number Title Priority Date Filing Date
IN130DEN2015 IN2015DN00130A (en) 2012-07-11 2015-01-06

Country Status (22)

Country Link
US (1) US9370576B2 (en)
EP (1) EP2873416B1 (en)
JP (1) JP6093015B2 (en)
KR (1) KR20150036228A (en)
CN (1) CN104487063B (en)
AP (1) AP2014008171A0 (en)
BR (1) BR112015000544A2 (en)
CL (1) CL2015000052A1 (en)
CO (1) CO7310521A2 (en)
EA (1) EA027712B1 (en)
GE (1) GEP201606571B (en)
IL (1) IL236562A0 (en)
IN (1) IN2015DN00130A (en)
MA (1) MA37693B1 (en)
MX (1) MX2015000467A (en)
PE (1) PE20150632A1 (en)
RU (1) RU2496486C1 (en)
SG (1) SG11201500178QA (en)
TN (1) TN2015000006A1 (en)
UA (1) UA113216C2 (en)
WO (1) WO2014011083A2 (en)
ZA (1) ZA201409481B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014110398A1 (en) 2013-01-10 2014-07-17 Edh Us Llc Ball spin rate measurement
RU2611415C1 (en) * 2015-11-17 2017-02-21 Общество С Ограниченной Ответственностью "Валента - Интеллект" Pharmaceutical composition possessing therapeutic effect on demyelinating diseases (versions)
WO2020005189A2 (en) * 2018-06-27 2020-01-02 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Solid oral pharmaceutical compositions comprising teriflunomide

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122011100012I1 (en) 1992-10-21 2011-10-20 Mitsubishi Tanabe Pharma Corp 2-amino-1,3-propanediol compound and immunosuppressant.
SK282225B6 (en) 1995-12-28 2001-12-03 Welfide Corporation Use of 2-amino-2[2-(octylphenyl)ethyl]-propane-1,3-diol or its pharmaceutically acceptable additive salt with acid for production of pharmaceutical preparation
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
GB9624038D0 (en) 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
JPH1180026A (en) 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd New immunosuppressant, its use and its identification
JP4627356B2 (en) * 1999-06-30 2011-02-09 松森  昭 Drugs for preventing or treating viral myocarditis
JP2002316985A (en) 2001-04-20 2002-10-31 Sankyo Co Ltd Benzothiophene derivative
RU2358717C2 (en) 2002-05-16 2009-06-20 Новартис Аг Application of edg-receptor binding agent in cancer therapy
PE20150676A1 (en) * 2003-04-08 2015-05-17 Novartis Ag PHARMACEUTICAL COMPOSITION CONTAINING AN S1P RECEPTOR AGONIST AND A SUGAR ALCOHOL
CA2539033C (en) * 2003-09-12 2013-03-05 Neuronova Ab Treatment of disease or injury of the nervous system with fty720
US20080096972A1 (en) 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds
GT200600350A (en) 2005-08-09 2007-03-28 LIQUID FORMULATIONS
MXPA05008573A (en) 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Isoflavones composition for treating menopause physiological symptoms and disorders.
EP1923058A1 (en) * 2006-09-26 2008-05-21 Novartis AG Coated pharmaceutical composition comprising an S1P agonist or modulator
KR102044064B1 (en) * 2006-09-26 2019-11-12 노파르티스 아게 Pharmaceutical compositions comprising an s1p modulator
KR101600098B1 (en) * 2007-10-12 2016-03-04 노파르티스 아게 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
CA2797042A1 (en) * 2010-04-22 2011-10-27 Ratiopharm Gmbh Fingolimod in the form of a solid solution
CA2797551A1 (en) * 2010-04-22 2011-10-27 Ratiopharm Gmbh Melt-granulated fingolimod

Also Published As

Publication number Publication date
EA201500096A1 (en) 2015-05-29
BR112015000544A2 (en) 2017-10-24
MA37693A1 (en) 2016-06-30
EA027712B1 (en) 2017-08-31
US20150335754A1 (en) 2015-11-26
MX2015000467A (en) 2015-06-05
TN2015000006A1 (en) 2016-06-29
JP2015522068A (en) 2015-08-03
EP2873416B1 (en) 2017-04-26
WO2014011083A2 (en) 2014-01-16
GEP201606571B (en) 2016-11-10
ZA201409481B (en) 2016-02-24
KR20150036228A (en) 2015-04-07
CN104487063B (en) 2017-05-10
US9370576B2 (en) 2016-06-21
IL236562A0 (en) 2015-02-26
MA37693B1 (en) 2017-01-31
PE20150632A1 (en) 2015-05-20
SG11201500178QA (en) 2015-03-30
JP6093015B2 (en) 2017-03-08
AP2014008171A0 (en) 2014-12-31
CL2015000052A1 (en) 2015-09-04
EP2873416A4 (en) 2016-03-16
CN104487063A (en) 2015-04-01
WO2014011083A3 (en) 2014-03-06
EP2873416A2 (en) 2015-05-20
RU2496486C1 (en) 2013-10-27
CO7310521A2 (en) 2015-06-30
UA113216C2 (en) 2016-12-26

Similar Documents

Publication Publication Date Title
BR112015006368A2 (en)
BR112014017635A2 (en)
BR112014017614A2 (en)
BR112014017625A2 (en)
BR112014019393A2 (en)
BR112014017659A2 (en)
BR112014017924A2 (en)
BR112014017646A2 (en)
AR092201A1 (en)
BR112014017638A2 (en)
BR112014019093A2 (en)
BR112014017634A2 (en)
BR112014017609A2 (en)
BR112014017644A2 (en)
BR112014017647A2 (en)
BR112014017618A2 (en)
BR112014017630A2 (en)
BR112014017652A2 (en)
BR112014017621A2 (en)
BR112014017622A2 (en)
BR112014017627A2 (en)
BR112014017623A2 (en)
BR112014019068A2 (en)
BR112014018104A2 (en)
BR112014017641A2 (en)